As we bid farewell to 2023, the Cancer Vaccine Institute is proud to share a year-in-review that underscores a journey of innovation, collaboration, and gratitude. From hosting our first patient reunion to gaining recognition for our cancer vaccines and immunotherapies, CVI remains steadfast in its commitment to making a meaningful difference in the lives of patients and their families.
To our patients, donors, collaborators, and research team, thank you for being an integral part of our mission to ignite the immune system to end cancer.
Take a look at our 2023 Year In Review Newsletter: https://mailchi.mp/7dd2bae801d8/2022-year-in-review-at-the-cvi-8393777?e=5e2fc1ab6c